Wireless EEG patches that move seizure monitoring out of hospital units and into patients' daily lives.
Epitel
venture active confidence: Medium status: Draft updated 2026-07-14
Summary
Epitel is a Salt Lake City company developing REMI, a wireless remote EEG monitoring system for healthcare-facility and ambulatory settings. Epilepsy diagnosis and treatment depend on recording seizures on EEG, but seizures are episodic.
Impact
Epilepsy diagnosis and treatment depend on recording seizures on EEG, but seizures are episodic. Many patients never have one during a standard one- to two-hour clinic study. The traditional workaround — multi-day inpatient video-EEG — is costly, hospital-bound, and inaccessible for rural, underinsured, or time-constrained patients.
Ambulatory EEG changes the diagnostic funnel: a patient wears a patch at home while living normally, and neurologists review continuous data — increasingly with AI-assisted event marking. If wearable EEG becomes routine, it could also support medication titration and longitudinal monitoring at scales inpatient units cannot reach.
What They Are Building
Epitel's product stack, per its official website, includes:
- REMI sensors — single-use, disposable, wireless scalp electrodes that capture brain electrical activity for up to 30 days.
- REMI Mobile — setup and notification software on qualified commercial mobile platforms.
- REMI Cloud — secure storage and preparation of EEG data for remote review.
- REMI Vigilenz AI for Event Detection — offline analysis that annotates previously acquired EEG with potential seizure-like events and confidence scores; it does not diagnose or operate in real time.
- Persyst Mobile integration — data flows to a widely used EEG review platform for qualified physicians.
The hard engineering problems are low-power, low-noise scalp EEG during daily activity (movement, muscle, and electrical artifact), plus seizure-detection models that balance sensitivity against reviewer overload.
What They Need Now
Likely needs include biomedical and electrical engineers, signal-processing and machine-learning engineers for seizure detection, regulatory affairs specialists, clinical-study operations staff, reimbursement and payer-strategy operators, and field clinical trainers. The company is small; individual contributors can have outsized impact.
Who Could Help
Useful helpers include FDA regulatory consultants for software-as-a-medical-device pathways, epilepsy clinical advisors, hospital neurology department champions, payer and coding specialists for ambulatory EEG reimbursement, and manufacturing partners for disposable sensor scale-up.
Utah Context
Epitel is headquartered in Salt Lake City and traces to the University of Utah Neural Engineering program. It sits alongside Blackrock Neurotech, SCI Institute, and the broader U of U spinout pipeline in a Wasatch Front cluster that punches above its weight in neural engineering and medical devices.
Evidence
See Also
- Blackrock Neurotech — Utah neighbor in implantable and systems-level neural interfaces
- SCI Institute — Utah academic infrastructure for neural engineering
- Utah Array BCI Platform — contrasting Utah neural-hardware lineage (intracortical versus scalp EEG)
Open Questions
- Careers URL: No agent-readable careers board found (2026-07-14). Workable board
https://apply.workable.com/epitel/andjobs.mdreturned 0 openings / failed readability check; Builtin jobs page also empty. Do not invent a Careers field until a readable ATS lists roles. - Market share versus ambulatory EEG competitors (Epilog, Ceribell ICU variants, Neurolutions, traditional extended EEG vendors) is not established on this page.
- Independent clinical outcomes data beyond company-cited publications should be reviewed before strong efficacy claims.
- Insurance coverage and reimbursement ceilings will likely determine deployment scale more than hardware performance alone.